Liver Physiology Flashcards

1
Q

Structure of ferritin

A

Large spherical protein consisting of 24 noncovalently linked subunits
Subunits form a shell surrounding a central core
Core contains up to 5000 atoms of iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Functions of the liver

A

Carbohydrate metabolism
Fat metabolism
Protein metabolism
Hormone metabolism
Toxin/drug metabolism and excretion
Storage
Bilirubin metabolism and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is ferrritin found

A

In cytoplasm of cells and can also be found in the serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the concentration of ferritin directly proportional to

A

Total iron stores in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Excess iron storage disorders

A

Hereditary haemochromatosis
Haemolytic anaemia
Sideroblastic anaemia
Multiple blood transfusions
Iron replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-iron overload

A

Liver disease
Some malignancies
Significant tissue destruction
Acute phase response:
-Inflammation
-Infection
-Autoimmune disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ferritin deficiency (iron deficiency)

A

Can result in anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ferritin less than 20ug/L

A

Depletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ferritin less than 12ug/L

A

Complete absence of stored iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Average amount of iron absorbed each day

A

1-2 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is iron absorbed in the body

A

Duodenum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where is iron stored

A

Liver parenchyma
Reticuloendothelial macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Iron utilisation

A

Myoglobin in muscle
Haemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which molecule stores iron

A

Ferritin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many atoms of iron can a molecule of ferritin store

A

Up to 5000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Number of subunits in ferritin

A

24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Function of vitamins

A

Gene activators
Free-radical scavengers
Coenzymes or cofactors in metabolic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Water soluble vitamin examples

A

Vitamin B and C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fat soluble vitamin examples

A

Vitamins A, D, E and K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vitamin A

A

Retinoids
Vertebrates ingest retinal directly from meat or produce retinal from carotenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sources of vitamin A

A

Retinols
Carotenoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Sources of carotenoids

A

Tomatoes
Spinach
Carrots
Sweet potato

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sources of retinols

A

Dairy
Eggs
Cereal
Meat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Male daily requirement of vitamin A

A

0.6 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Female daily requirement of vitamin A
0.7 mg/day
26
Vitamin A functions
Vision Reproduction Growth Stabilisation of cellular membranes
27
Vitamin A and vision
Used to form rhodopsin in the rod cells of the retina
28
Vitamin A and reproduction
Spermatogenesis in male Prevention of fetal resorption of female
29
Vitamin A deficiency
Rare in affluent countries as vitamin A levels drop only when liver stores are severely depleted. Deficiency may occur due to fat malabsorption Clinical Features: -Night blindness -Xeropthalmia -Blindness
30
Clinical features of vitamin A deficiency
Night blindness Xerophthalmia- inability to produce tears Blindness
31
What molecules does the liver store
Ferritin Vitamins Clotting factors
32
Acute vitamin A excess
Abdominal pain, nausea and vomiting Severe headaches, dizziness, sluggishness and irritability Desquamation of the skin
33
Chronic vitamin A deficiency
Joint and bone pain Hair loss, dryness of the lips Anorexia Weight loss and hepatomegaly
34
Storage of water soluble vs fat soluble vitamins
Water soluble vitamins pass more readily through the body so require more regular intake than fat soluble vitamins Fat soluble vitamins more readily stored
35
Carotenemia and vitamin A excess
Reversible yellowing of the skin Does not cause toxicity
36
Vitamin D functions
Increased intestinal absorption of calcium Resorption and formation of bone Reduced renal excretion of calcium
37
Sources of vitamin D
Sunlight Vitamin D3 = fish, meat Vitamin D2= supplements
38
Vitamin D deficiency
Demineralisation of bone: - rickets in children - osteomalacia in adults
39
Where is vitamin E stored
Non-adipose cells such as liver and plasma - labile and fixed pool Adipose cells- fixed pool
40
Function of vitamin E
Important antioxidant
41
Male daily vitamin E requirements
4 mg/day
42
Female vitamin E daily requirements
3 mg/day
43
Sources of vitamin E
Nuts Oils Avocado Carrots Spinach
44
Causes of vitamin E deficiency
Fat malabsorption eg cystic fibrosis Premature infants Rare congenital defects in fat metabolism eg abetalipoproteinaemia
45
Vitamin D3
Cholecalciferol
46
What does liver convert vitamin D3 to
25-hydroxyvitamin D3
47
Which molecule maintains calcium balance in the body
1,25-dihydroxyvitamin D3
48
Which organ converts 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D
Kidney
49
Clinical manifestations of vitamin E deficiency
Haemolytic anaemia Myopathy Retinopathy Ataxia Neuropathy
50
Vitamin E excess
Relatively safe
51
Fixed pool of vitamin E
Adipose cells
52
Labile and fixed pool of vitamin E
Non-adipose cells such as liver and plasma
53
Types of vitamin K
K1 K2 K3 K4
54
Vitamin K1
Phylloquinone Synthesised by plants and present in food
55
Vitamin K2
Menaquinone Synthesised in humans by intestinal bacteria
56
Synthetic vitamin Ks
K3 K4
57
Vitamin K3
Menadione Synthetic
58
Vitamin K4
Menadiol Synthetic
59
Vitamin K and the liver
Rapidly taken up by the liver Transferred to very low density lipoproteins (VLDL) and low density lipoproteins (LDL) which carry it into the plasma
60
Functions of vitamin K
Activation of some blood clotting factors Necessary for liver synthesis of plasma clotting factors II, VII, IX , X
61
How to measure vitamin K levels
Prothrombin time
62
Sources of vitamin K
Green leafy vegetables Sunflower pil
63
Vitamin K deficiency
Haemorrhagic disease of the newborn: vitamin K injection given to newborn babies Rare in adults unless on warfarin
64
Vitamin K excess
K1 is relatively safe Synthetic forms are more toxic Can result in oxidative damage, red cell fragility and formation of methaemoglobin.
65
Functions of vitamin C
Collagen synthesis Antioxidant Iron absorption
66
Adult daily requirement of vitamin C
40 mg/day
67
Sources of vitamin C
Fresh fruit Vegetables
68
Vitamin C deficiency
Scurvy: Easy bruising and bleeding Teeth and gum disease Hair loss
69
Treatment of vitamin C deficiency
Treated with vitamin C Improves symptoms quickly Joint pain gone within 48 hours Full recovery within 2 weeks
70
Vitamin C excess
Doses > 1g/day can cause GI side effects No evidence that increased vitamin C reduces the incidence or duration of colds.
71
Vitamin B12
Cobalamins
72
2 active forms of vitamin B12
Methylcobalamin 5-deoxyadenosylcobalamin
73
Where is vitamin B12 released from
Food by acid and enzymes in stomach
74
Transportation of vitamin B12
Binds to R protein to protect it from stomach acid Released from R proteins by pancreatic polypeptide Intrinsic factor produced by the stomach needed for absorption IF-B12 complex absorbed in terminal ileum
75
Where is vitamin B12 stored
Liver
76
Where is intrinsic factor produced
Stomach
77
Which protein protects vitamin B12 from stomach acid
R protein
78
What molecule is needed for absorption of Vitamin B12
Intrinsic factor
79
Where is IF-B12 complex absorbed
Terminal ileum
80
Sources of Vitamin B12
Meat Fish Eggs Milk
81
Which enzyme releases vitamin B12 from R protein
Pancreatic polypeptide
82
Causes of vitamin B12 deficiency
Pernicious anaemia – autoimmune destruction of IF-producing cells in stomach. Malabsorption – lack of stomach acid, pancreatic disease, small bowel disease. Veganism
83
Symptoms of vitamin B12 deficiency
Macrocytic anaemia Peripheral neuropathy in prolonged deficiency
84
Folate
found in may foods fortified with folic acid. Individuals have higher requirements in pregnancy.
85
Functions of folate
Coenzyme in methylation reactions DNA synthesis Synthesis of methionine from homocysteine
86
Causes of folate deficiency
Malabsorption Drugs that interfere with folic acid metabolism (anticonvulsants, methotrexate) Disease states that increase cell turnover (e.g. leukaemia, haemolytic anaemia, psoriasis)
87
Symptoms of folate deficiency
High homocysteine levels Macrocytic anaemia Foetal development abnormalities (neural tube defects)
88
Clotting factors
Intrinsic pathway activated by contact Extrinsic pathway activated by FVII coming in contact with tissue factor Initiates a cascade which ultimately results in fibrin clot formation
89
What is intrinsic clotting pathway activated by
Contact
90
What is extrinsic clotting pathway activated by
FVII coming in contact with tissue factor
91
Clotting factors produced by the liver
I (fibrinogen) II (prothrombin) IV V VI VII
92
Performance of clotting pathways measured using
Prothrombin time (extrinsic pathway) International normalised ratio Activated partial thromboplastin time (aPTT) (intrinsic pathway)
93
What measures extrinsic clotting factor
Prothrombin time
94
What measures intrinsic clotting pathway
Activated partial thromboplastin time
95
Prolonged PT
May indicate a deficiency in the synthetic capacity of the liver
96
Causes of prolonged prothrombin time
Liver disease DIC severe GI bleeding Some drugs Vitamin K deficiency
97
Unwanted dietary components
Xenobiotics
98
How many phases are there of biotransformation reactions
2
99
Phase I biotransformation reactions
Functionalisation - non synthetic Add or expose functional groups -OH, -SH, -NH2, -COOH
100
Phase II biotransformation reactions
Conjugation- biosynthetic Conjugation with endogenous molecules: glucuronic acid, sulphate, glutathione Covalent bonds formed
101
Purpose of xenobiotic biotransformation reactions
Make compounds non-toxic and water soluble
102
Xenobiotics
foreign substances that don’t have nutritional value. Xenobiotic compounds are mostly in the diet, but we also breathe in potential toxins, and importantly the body treats medications as xenobiotics.
103
Phase I and hydrophilicity
Small increase
104
Phase II and hydrophilicity
Large increase
105
Glucuronides
Polar and hydrophilic Eg paracetamol
106
glucuronyl group
has a number of hydroxyl groups which make the molecule polar and facilitate excretion in the urine.
107
Where does detoxification take place
Most in liver some takes place in the lungs & small intestine before compounds are absorbed into the bloodstream.
108
Detoxification in liver
* inactivation and facilitated elimination of drugs and other xenobiotics * active metabolites formed, with similar or occasionally enhanced activity * activation of pro-drugs * toxification of less toxic xenobiotics
109
Where does biotransformation occur in liver cells
Smooth endoplasmic reticulum
110
Coding for cytochrome P450 enzymes
Encoded by a superfamily of more than 50 different genes in humans
111
Common features of cytochrome P450 enzymes
All present in sER- microsomal enzymes All oxidise the substrate and reduce oxygen All have a cytochrome reductase subunit which uses NADPH Are inducible- enzyme activity may be increased by certain drugs, some dietary components and some environmental toxins eg smoking Generate a reactive free radical compound
112
What can cytochrome P450 enzymes be induced by
Certain drugs, some dietary components, some environmental toxins eg smoking
113
What does the cytochrome reductase subunit use
NADPH
114
Phase I reactions- oxidation
Hydroxylation (addition of -OH groups) N- and O- dealkylation (removal of -CH side chains) Deamination (removal of -NH side chain) Epoxidation (formation of epoxides)
115
Phase I reactions - reduction
Hydrogen addition (unsaturated—>saturated) Donor molecules include GSH, FAD, NAD(P)H
116
Phase I reactions - hydrolysis
Splitting of C-N-C (amide) and C-O-C (ester) bonds
117
Reason for biotransformation reactions
To be filtered and excreted in the urine a molecule needs to be polar (thus more hydrophilic) increasing its solubility Can occur via 2 methods
118
Phase II reactions
Glycoside conjugation - glucuronidation (most common) Sulphate - sulphation Glutathione (GSH)
119
Example of molecule that can go straight to phase II biotransformation reactions
Morphine
120
Pharmacokinetics
A = absorption D - distribution M = metabolism E = elimination/excretion
121
Effect of xenobiotics
Damage proteins, lipids and can bind to DNA (carcinogens)
122
Mechanism of Xenobiotics
React with O2 and release free radicals
123
Why do most medications require 2 phase biotransformation
Tend to be lipophilic, non-polar and non-ionised at physiological pH to allow pharmaceutical action
124
Location of microsomal enzymes
Smooth ER of liver, kidneys and intestinal mucosa
125
Microsomal enzymes
Mono-oxygenases (CYPs, FMOs)
126
Reaction of microsomal enzymes
Majority of drug biotransformation
127
Are microsomal enzymes inducible
Yes by diet and drugs
128
Location of non-microsomal enzymes
Cytoplasm and mitochondria of hepatocytes
129
Non-microsomal enzymes
Protein oxidases, esterases etc
130
Reaction of non-microsomal enzymes
Non-specific enzymes for conjugation
131
Are non-microsomal enzymes inducible
No but have polymorphisms
132
Which organ excretes drugs and metabolites
Kidney
133
When are cytochrome-P450 enzymes required
Phase I biotransformation
134
Which cytochrome-P450 enzyme is in highest concentration
CYP3A4 Responsible for 2/3 all known drugs
135
How many main groups of cytochrome-P450 are there
At least 10
136
Enzyme induction of cytochrome-P450
Molecule binds to an intracellular receptor within the cytoplasm This molecule-receptor complex migrates to the nucleus Increases transcription of mRNA for cytochrome-P450s Increases the effect of the CYP One substance can induce a number of enzymes
137
cytochrome-P450 mechanism of action
Contain a haem component which is capable of oxidising molecules (-OH addition) by becoming reduced themselves The reductase use NADPH to become active It reduces CYPs allowing the oxidation of the foreign molecule Reaction forms water and has an intermediate of a haem free radical Overall the addition of the -OH group increases the solubility of the molecule
138
What 3 things can metabolism of compounds results in
Complete inactivation and elimination Formation of another active compound Activation of pro-drugs Toxification of less toxic Xenobiotics Active drug to reactive intermediates
139
Phase III
Removal of drugs/ metabolites by transporter-mediated elimination via the liver gut kidney and lung
140
Where does phase III occur
Liver Gut Kidney Lung
141
Complete inactivation and elimination
Eg phenobarbital (barbiturate derivative) Metabolised using phase I and II distributed into fat and bound to plasma proteins so metabolism is slow
142
Formation of another active component
Can have similar or new activity Eg codeine breaking down into morphine Eg diazepam into oxazepam
143
Activation of pro-drugs
Eg hetacillin converted into ampicillin Eg into-glycerine into nitric oxide
144
Active drug to reactive intermediates
Eg benzopyrene in cigarette smoke Bind to DNA and induce CYPs which increase epoxide levels
145
CYP and smoking
CYP1A2 can be induced by smoking This increased activity has effects on metabolism of other molecules Eg clozapine- dose has to be tightly controlled depending on how much the patient smokes
146
CYP and grapefruit
Grapefruit juice has effects on medications eg statins Contains products that inhibit CYPs Statins become more potent Grapefruit is contraindicated
147
CYP2E1 and paracetamol
Usually disposed of safely by glucuronidation (50%) as glucuronide has a lot of -OH groups, also by sulfation (40%) Harmful intermediate NAPQI is created from CYP2E1 (10%) If normal pathways are overwhelmed, CYP2E1 becomes more significant and more NAPQI created- normally metabolised by glutathione-S-transferase but this is overwhelmed by high levels Hepatocytes then become damaged
148
CYP2E1 and ethanol
Uses the same enzyme as paracetamol so has a dual effect when taken together Enzymes are induced by 2 factors More likely to go done the harmful route- enzymes overwhelmed
149
Treatment for paracetamol overdose
Acetylcysteine
150
Acetaminophen——> conjungation ——> elimination
Glucuronidation Sulfation
151
Acetaminophen——> NAPQI
CYP450
152
NAPQI ——> conjugation ——> elimination
GSH
153
NAPQI ——> adducts NO-, O2 nitration peroxidation ——> cell death
GSH-depletion
154
Ethanol and alcohol dehydrogenase
Alcohol is polar but also slightly lipid soluble Can be excreted (2-10%) but is more commonly used as fuel Metabolised in acetaldehyde (tocis) Further metabolism to acetate by ALDH which can be used in Kreb’s cycle This second metabolism becomes overwhelmed and acetaldehyde builds up
155
What percentage of ethanol is excreted
2-10%
156
First metabolism reaction of ethanol
Acetaldehyde
157
Acetaldehyde—> acetate
ALDH
158
What is acetaldehyde converted to
Acetate
159
Ethanol and microsomal system- uses CYP2E1
Microsomal ethanol oxidising system (MEOS) also produces acetaldehyde Chronic alcohol use increases CYP2E1 levels 5-10 fold therefore alcohol is metabolised quicker Acetaldehyde is produced quicker and in larger quantities- more toxic Results in liver damage from the production of free radicals
160
2 processes that produce acetaldehyde from ethanol
Microsomal ethanol oxidising system Alcohol dehydrogenase
161
Inhibition cytochrome P450 enzymes
can result in increased blood concentrations of certain medications (less breakdown).
162
Suitable molecule that can bind to nuclear hormone receptor
phenobarbital
163
Vitamin D produced in the body
Cholecalciferol
164
Vitamin D found in food
Ergocalcaiferol
165
Which vitamin protects vitamin A
Vitamin E
166
How much vitamin B12 is stored in the body
2-5 mg
167
What percentage of vitamin B12 is stored in the liver
50%
168
Vitamin metabolism
Liver is important in metabolic activation of vitamin D
169
3 types of jaundice
pre-hepatic, hepatic or post-hepatic
170
Pre-hepatic jaundice
caused by increased haemolysis- results in increased presence of unconjugated bilirubin in the blood as the liver is unable to conjugate it all at the same rate • Any bilirubin that manages to become conjugated will be excreted normally, yet it is the unconjugated bilirubin that remains in the blood stream to cause the jaundice.
171
Causes of pre-hepatic jaundice
• Tropical disease eg malaria, yellow fever • Genetic disorders eg sickle-cell anaemia, Gilbert’s syndrome • Haemolytic anaemias
172
Hepatic jaundice
caused by liver impairment- causes the decreased ability of the liver to conjugate bilirubin, resulting in the presence of conjugated and unconjugated bilirubin in the blood • The liver loses the ability to conjugate bilirubin, but in cases where it also may become cirrhotic, it compresses the intra-hepatic portions of the biliary tree to cause a degree of obstruction. This leads to both unconjugated and conjugated bilirubin in the blood
173
Causes of hepatic jaundice
• Viral hepatitis • Hepatotoxic drugs eg paracetamol overdose, alcohol abuse
174
Post-hepatic jaundice
caused by the blockage of bile ducts- results in back-flow of conjugated bilirubin into the blood as it cannot move past the obstruction • bilirubin that is not excreted will have been conjugated by the liver, hence the result is a conjugated hyperbilirubinaemia.
175
Causes of post-hepatic jaundice
Gallstones • Hepatic tumours • Pancreatic tumours
176
Gilbert’s syndrome
• inherited disorder where there is hyperbilirubinaemia (excess bilirubin in bloodstream) due to a fault in the UGT1A1 gene leading to a deficiency in UPD-gluconoryltransferase. • Results in slower conjugation of bilirubin in the liver so it builds up in the bloodstream • When well, patients are usually asymptomatic and have normal bilirubin levels • Under physiological stressors such as illness, alcohol abuse and extreme exercise, patients can become markedly jaundiced
177
Why does jaundice give you dark urine
excessive conjugated bilirubin excreted through the kidneys
178
Why does jaundice give you pale stool
reduced levels of stercobilin entering the GI tract. Obstructive or post-hepatic liver cause as normal faeces get their colour from bile pigments
179
Hepatobiliary system
Between adjacent hepatocytes, grooves in the cell membranes provide room for bile canaliculi: these are small ducts that accumulate the bile produced by hepatocytes. Bile flows first into bile ductules and then into bile ducts which unite to form the larger left and right hepatic ducts. These merge and exit the liver as the common hepatic duct. The common hepatic duct then joins with the cystic duct (from the gallbladder), forming the common bile duct which flows into the duodenum.
180
Bilirubin
yellow bile pigment produced through the breakdown of red blood cells (haemolysis). It is metabolised prior to excretion through the faeces and urine. Bilirubin exists in 2 forms: conjugated and unconjugated. Unconjugated bilirubin is insoluble in water so can only travel in the bloodstream if bound to albumin and cannot be directly excreted from the body. Whereas, conjugated bilirubin is water soluble so it can travel in the bloodstream and excreted out of the body.
181
2 forms of bilirubin
Conjugated and unconjugated
182
Unconjugated bilirubin
insoluble in water so can only travel in the bloodstream if bound to albumin and cannot be directly excreted from the body
183
Conjugated bilirubin
water soluble so it can travel in the bloodstream and excreted out of the body.
184
Creation of bilirubin
reticuloendothelial cells are macrophages which are responsible for the maintenance of blood through destruction of old or abnormal cells. They take up red blood cells and metabolise the haemoglobin present into its individual components: haem and globin. Globin is further broken down into amino acids which are recycled. Haem is broken down into iron and biliverdin, catalysed by haem oxygenase. The iron is recycled and the biliverdin is reduced to form unconjugated bilirubin.
185
Bilirubin conjugation
In the bloodstream, unconjugated bilirubin binds to albumin to facilitate its transport to the liver. In the liver, glucuronic acid is added to unconjugated bilirubin by the enzyme glucuronyl transferase. This forms conjugated bilirubin, which is soluble, allowing it to be excreted into the duodenum in bile.
186
Bilirubin excretion
Once in the colon, colonic bacteria deconjugate bilirubin and convert it into urobilinogen. Around 80% is further oxidised by intestinal bacteria and converted to stercobilin and then excreted through faeces (giving it its colour). Around 20% of the urobilinogen is reabsorbed into the bloodstream as part of enterohepatic circulation. It is carried to the liver where some is recycled for bile production, and a small percentage reaches the kidneys. In the kidneys, it is further oxidised to urobilin and then excreted into the urine.
187
Which cells destroy old or damaged red blood cells (haemolysis)
reticuloendothelial cells
188
What is haemoglobin metabolised into
Haem and globin
189
What is globin broken into
Amino acids which are recycled
190
What is haem broken down into
Iron and biliverdin
191
Which enzyme breaks down haem
Haem oxygenase
192
What happens to the iron produced by haemolysis
It is recyled
193
What happens to biliverdin
It is reduced to form unconjugated bilirubin
194
What must unconjugated bilirubin bind to in order to be transported in blood
Albumin
195
Where is unconjugated bilirubin conjugated
Liver
196
Which enzyme conjugates bilirubin
glucuronyl transferase
197
What is added to unconjugated bilirubin to form conjugated bilirubin
Glucuronic acid
198
How is conjugate bilirubin excreted from the liver
In the bile into the duodenum
199
What happens to conjugated bilirubin in the colon
Colonic bacteria deconjugates it forming urobilinogen
200
What is formed in the colon from conjugated bilirubin
Urobilinogen
201
What happens to 80% of the urobilinogen
further oxidised by intestinal bacteria and converted to stercobilin and then excreted through faeces (giving it its colour)
202
What gives faeces its colour
Stercobilin
203
What happens to 20% of the urobilinogen formed
reabsorbed into the bloodstream as part of enterohepatic circulation. It is carried to the liver where some is recycled for bile production, and a small percentage reaches the kidneys. In the kidneys, it is further oxidised to urobilin and then excreted into the urine.
204
Where is urobilinogen metabolised before excretion in the urine
Kidneys
205
What is urobilinogen oxidised to in the kidneys
Urobilin
206
What is urobilinogen oxidised to by intestinal bacteria
Stercobilin
207
Scheme of principal blood flow through the liver
Heart —> abdominal aorta —> hepatic artery proper —> liver —> hepatic veins —> inferior vena cava —> heart
208
Microanatomy of liver
Organised in lobules with a central hepatic wein Hexagon- portal triads in the corners
209
Number of functions of the liver
Approximately 500
210
Main functions of liver
Detoxification - filters and cleans blood of waste products (drugs, hormones) Immune functions - fights infections and diseases (RE system) Involved in synthesis of clotting factors, proteins, enzymes, glycogen and fats Production of bile and breakdown of bilirubin Energy storage- glycogen and fats Regulation of fat metabolism Ability to regenerate
211
Metabolic role of the liver
Maintains a continuous supply of energy for the body by controlling the metabolism of CHO and fats
212
What is the liver regulated by
Endocrine glands eg pancreas, adrenal, thyroid Nerves
213
Lipid definition
Esters of fatty acids and glycerol or other compounds (cholesterol) Large and diverse group of naturally occurring organic compounds that are insoluble in water Variety of structure and functions
214
Tri(acyl)glycerides TG, TAG
1 glycerol molecule esterified to 3 fatty acids bonded at carboxylate head
215
Function of triglyceride
Storage form of fat in our body -adipocytes -hepatocytes -elsewhere
216
Saturated fatty acid
Lining up close together Esters are solid at room temperature Solid ‘fats’
217
Unsaturated fatty acids
Needs more space due to kink in chain Less tightly packed MUFA, PUFA Esters are liquid at room temperature ‘Oils’
218
Lipid functions
Energy reserve Structural and other functions Hormone metabolism
219
Lipid functions: structural and other functions
Part of cell membranes Integral to form and functions of cells Inflammatory cascade (LC-PUFAs precursors to eicosanoids, eg prostaglandins)
220
Lipid functions: inflammatory cascade
LC-PUFAs precursors to eicosanoids e.g. prostaglandins
221
Lipid functions: hormone metabolism
Cholesterol is backbone of adrenocorticoid and sex hormones Vitamin D
222
Lipids yield how much energy per gram
9-10 kcal
223
Lipid reserve 100000 kcal can last how long
30-40 days
224
Lipid transport
Often transported as TGs or FAs bound to albumin or within lipoproteins Triglycerides cannot diffuse through cell membrane Fatty acids are released through lipases to facilitate transport into cells- in the cell re-esterified to triglycerides
225
Fatty acid uptake
Diffusion through the lipid bilayer of the cell membrane Facilitated transport
226
Facilitated transport of fatty acids
Increases if increased substrate or increase in receptor molecules Several transporter systems
227
Transporter systems for facilitated diffusion of fatty acids
FA binding protein = mitochondrial AST - induction to increased expression may result in increased uptake of fatty acid in hepatocytes FAT -fatty acid translocase FATP- fatty acid transport polypeptide
228
Trans fats
Hardly kinked Hard to metabolise
229
What percentage of dietary fats of triglycerides
90%
230
Proportion of western diet that are dietary fats
1/3
231
What inhibits absorption of cholesterol in small intestine
Ezetimibe
232
Bile acids
polar derivates of of cholesterol - aid diestestion of fats and fat soluble vitamins Ba are amphipathic and emulsify fat globules into smaller miclelles -= hence higher surface area for lipid hydrolysing emzymes – they act as detergents (washing up liquid)
233
Secretion of bile acids and cholesterol
Secretion of BA and cholesterol through bile is the only excretion mechansim of cholesterol
234
Enterohepatic circulation
Reabsorption of bile acids and cholesterol in the ileum
235
What can disrupt reabsorption of cholesterol in ileum
Resins- like cholestyramine Diet- oat, bran fibre and fruit pectins
236
Chylomicrons
From the gut are transported through the lymphatic system to be delivered to muscle and adipose tissue, bypassing the liver- protects the liver from a large fatty acid influx
237
5 ways lipids accumulate in the liver
Excess intake - triglycerides in Chylomicrons remnants reach liver Increased de novo synthesis Increased fatty acid influx from lipolysis in adipocytes Reduced export Reduced oxidation in liver
238
Action of insulin
Fat storage in adipocytes Stimulates LPL (lipoprotein lipase)—> breakdown of triglycerides, releases free fatty acids to store )in form of TG) in adipocytes Reduced activity of hormone sensitive lipase (HSL) leading to reduced fatty acid export from adipocytes
239
Insulin resistance
Increased lipolysis in adipocytes leading to increased triglyceride in circulation Increased ‘offer’ of fatty acids to hepatocytes leading to increased uptake Increased glucose level leads to less demand for lipids to be used as energy source
240
Normal fatty acid uptake into hepatocytes
Lipoprotein lipase —> free fatty acids —> facilitated diffusion into adipocytes—> triglycerides—> hormone sensitive lipase —> free fatty acid -> hepatic lipase —> facilitated diffusion into hepatocytes
241
Enzymes involved in uptake of fatty acids
Lipoprotein lipase Hormone sensitive lipase Hepatic lipase
242
What is De novo lipogenesis in the liver dependent on
Insulin concentration and sensitivity
243
Purpose of hepatic de novo lipogenesis
Export in lipoproteins as energy source and structural components for membranes
244
De novo lipogenesis in the liver
Sequential extension of alkanoic chain staring from Acetyl-CoA via serial decarboxylative condensation reactions
245
Control of de novo lipogenesis in the liver
Nutrition and hormones High KH diet increases hepatic lipogenesis- KH are burnt to generate ATP, surplus glucose fills glycogen stored and further surplus is converted to fatty acids Fasting and fat feeding inhibit it
246
De novo lipogenesis in adipocytes
Long term energy storage
247
SREBP-1c
Activated fatty acid synthase
248
ChREBP
Carbohydrate response element binding protein
249
Dietary protein intake
0.75g/kg/day
250
Loss of nitrogen
Faecal loss- 10g/day Renal excretion- 70g/day in form of urea Skin/hair/sweat loss
251
Positive nitrogen balance examples
Pregnancy Lactation Bodybuilder and anabolic steroids Recovery ohase
252
Negative nitrogen balance examples
Protein malnutrition Severe illness/sepsis/trauma/burns Corticosteroids Cahexia: malignancy/heart failure/uraemia Essential amino acid deficiency
253
Nitrogen balance
concept that compares the amount of nitrogen (overwhelmingly in the form of dietary proteins) that enters the body compared to that which is excreted from the body. Nitrogen is said to be in balance when the two are roughly equal (+/- 4g/day)
254
Positive nitrogen balance
Intake of nitrogen greater than excretion Anabolic- gain of protein
255
Negative nitrogen balance
Excretion is greater than intake Catanolism- loss of protein
256
3 main fates of amino acids
they can be incorporated ‘as is’ with other amino acids to form peptides and proteins they can be modified to form other biomolecules such as nucleotide bases and neurotransmitters they can have their nitrogenous amino group removed (to be excreted as urea) and have their ‘carbon backbone’ reutilised for energy, either via the Citric acid cycle or through the formation of glucose via gluconeogenesis. No amino acid is stored.
257
Kwashiorkor
Adequate calories but inadequate proteins Protein-energy metabolism Features: oedema , fatty liver, dermatoses
258
Marasmus
Both protein and calories insufficient
259
Amino acid metabolism: fed state
Amino acids are absorbed from the gut and enter the portal circulation where they travel to the liver, which is the centre for the majority of metabolic processes. Accordingly, it is also the site where most of the humoral, that is to say, blood-bourne proteins are formed. They may be utilised here in protein formation, or be used to form other nitrogen-containing compounds. Some enter the systemic circulation to supply the builiding blocks of protein to different bodily tissues. Those which cannot be used in such a fashion have their amino groups removed and their carbon backbones used as metabolic substrates, helping to form carbohydrates like glucose from gluconeogenesis or fatty acids to form triacylglycerols.
260
GI proteolysis
Dietary protein —> denatured protein —> oligopeptides and AAS —> amino acids in blood stream (active transport)
261
What converts dietary protein to denatured protein
HCl and pepsin in stomach
262
What converts denatured protein to oligopeptides and AAs
Chymotrypsin Trypsin Aminopeptidase In small intestine
263
What converts oligopeptides and AAs to amino acids in bloodstream
Enterocyte peptidases In enterocytes
264
Transportation of free amino acid into enterocyte
first stage is via a cell surface channel where it is cotransported with a sodium ion. Then via the basal membrane is is actively transported into the portal veinous circulation by an ATP consuming process. From there it travels into the liver.
265
Glucogenic amino acids
Carbon backbone produces gluconeogenic/TCA cycle intermediates
266
Ketogenic amino acids
Carbon backbone produces Acetyl-CoA/ Acetoacetyl-CoA
267
Which amino acids are solely ketogenic
Leucine Lysine
268
Essential amino acids
Phenylalanine Valine Leucine Isoleucine Tryptophan Methionine Threonine Histidine
269
What are essential amino acids
Cannot be synthesised de novo in vivo
270
Important hepatic proteins
Albumin Coagulation factors IGF-1 C-reactive protein Carrier proteins eg caeruloplasmin Apolipoproteins
271
Importance of albumin
Maintains oncotic blood pressure Important carrier protein eg for sex hormones, magnesium, calcium and drugs
272
Glycine derivatives
Heme Creatinine Purine bases
273
Biosynthetic pathways for nitrogen from amino acids
Can produce non-peptide molecules eg neurotransmitters, nitric oxide and nucleotides
274
Aspartate derivatives
Purine and pyrimidine bases
275
Arginine derivatives
Nitric oxide
276
Tryptophan derivatives
Serotonin Melotonin
277
Tyrosine derivatives
Dopamine Catecholamines (enable fight or flight response) Thyroid hormones Melanin
278
Alpha-ketoacid
Carbon backbone after R group of amino acid cleaved Used in kreb’s cycle eg alanine —>pyruvate
279
Transamination enzyme
Aminotransferase (with PLP group)
280
Transamination of alanine
Alanine + Alpha-ketoglutatate <—> pyruvate + glutamate Alanine aminotransferase (ALT)
281
Transamination
In most transamination reactions, a-ketoglutarate and glutamate form one of the a-ketoacid/amino acid pairs. This means a-ketoglutarate is a receiver of nitrogen (the amino group), which is transferred to glutamate.
282
Fate of nitrogen after degradation of amino acids
Forms ammonia (NH4+) which is combined with bicarbonate to form carbamyl phosphate Enters urea cycle to produce urea which is excreted
283
What enzyme converts glutamate to alpha-ketoglutarate
Glutamate dehydrogenase
284
Other products when glutamate converted to alpha-ketoglutarate
NADP + H20 ——> NADPH + NH4+ (ammonium)
285
What two molecules form carbamyl phosphate
Ammonium and bicarbonate
286
Causes of Protein degradation
Faulty/aging/obsolete proteins Signal transduction Flexible system to meet protein/energy requirements of environment
287
Main means of protein degradation
Proteasome (ubiquitin-dependent) Lysosome
288
Ubiquitin
Mark of death Small protein Carboxyl group forms isopeptide bond with multiple lysine residues Formation of ubiquitin chains (stronger signal, especially >4)
289
3 Enzymes involved with ubiquitin
Ubiquitin-activating enzyme Ubiquitin-conjugating enzyme Ubiquitin-protein ligase
290
Proteasome
The executioner
291
N-terminal rule
N-terminal residues determine protein half-life PEST sequences (proline, glutamate, serine, threonine) Cyclin destruction box
292
Lysosomes
Proteolytic enzymes within lysosome separated from cytosolic components
293
4 types of lysosomal mechanisms
Macroautography Microautography Chaperone-mediated autographs Endocytosis/phagocytosis
294
Macroautography
Non-selective ER derived autophagisomes engulf cytosolic proteins/aggregates organelles Lysosome fuses with this to initiate proteolysis
295
Microautophagy
Non-selective Invaginations of lysosomal membrane engulf proteins/organelles
296
Chaperone-mediated autographs
Selective Chaperone protein hsc70 in cytosolic and intralysomal accompany specific cytosolic proteins in response to stressors (fasting/oxidative stress etc)
297
Endocytosis/phagocytosis
Extracellular substances
298
Cystinosis
Autosomal recessive condition 1 in 200000 Defect in transporter leads to cystine accumulation in tissue lysosomes Eye and kidney problems
299
Cortisol activates
Proteolysis Gluconeogenesis
300
Cortisol inhibits
Protein synthesis
301
Alanine - amino acid catabolism
Glucose-alanine cycle transports nitrogen from amino acid breakdown from the tissues to the liver, whilst recycling a carbon backbone that can be converted to glucose for energy
302
Glutamine - amino acid catabolism
Formed from BCAA degradation in the tissues In the fasting state, it is an important metabolic fuel for the kidney and gut and provides ammonia to buffer proton diuretics in metabolic acidosis states
303
Branched chain amino acids - amino acid catabolism
Isoleucine/valine/leucine Major amino acids that can be oxidised in tissues other than the liver, especially skeletal muscle
304
Glucagon - amino acid catabolism
Stimulates: Glycogenolysis Gluconeogenesis Amino acid degradation Ureagenesis Entry of amino acids to liver
305
What percentage of cholesterol is endogenous
90%
306
What percentage of cholesterol is dietary
10%
307
Excretion of cholesterol
Through bile Enterohepatic circulation
308
Cholesterol is esterified intracellularly in lipoprotein by
Acyl-CoA or by lecithin by cholesterol acyltransferase
309
Which enzymes esterifies cholesterol
Cholesterol acyltransferase
310
What do lipoproteins consist of
A core containing triglycerides and cholesterol-esters A surface monolayer of phospholipids cholesterol and specific proteins (eg apoproteins)
311
What determine the density of lipoproteins
Protein to lipid ratio
312
Types of lipoprotein
Chylomicrons VLDL LDL HDL
313
Chylomicrons lipoproteins
Largest lowest density High lipid to protein ratio Highest triglyceride content
314
VLDL
Very low density lipoprotein 2nd highest in triglycerides as percentage of weight
315
LDL
Low density lipoprotein High cholesterol ester as percentage of weight Raised by saturated fats and trans fatty acids
316
HDL
High density lipoprotein Low lipid to protein ratio
317
Chylomicrons remnant
Taken up by the liver via receptor-mediated Endocytosis Recognition of ApoE by hepatocyte surface receptors
318
Where is Apoprotein B synthesised
Rough ER
319
Fatty acid export
Microsomal TAG transfer protein adds the lipid components to ApoB Transported in vesicle to Golgi apparatus where ApoB is glycosylates This buds off the Golgi and migrate the sinusoidal membrane of the hepatocytes Vesicle fuse with the membranes and VLDL is released
320
What is fatty acid export rate limiting for
VLDL production
321
What combines the lipid components to ApoB
Microsomal TAG transfer protein
322
Where is ApoB glycosylated
Golgi apparatus
323
Rate limiting steps of lipogenesis
Acetyl-CoA —> Malonyl-CoA Catalysed by Acetyl-CoA carboxylase Rate is also related to FAS-FA synthetase
324
What converts acetyl-CoA to malonyl-CoA
Acetyl-CoA carboxylase
325
Lipogenesis and fasting
Reduced in fasting Hepatic glycogen stores depleted Triglycerides broken down in adipocytes and more free fatty acids released Oxidised in the liver as an energy source
326
Inflow into the liver of lipids from
Portal vein Hepatic artery Lymphatics
327
Lipids enter liver in form of
Triglycerides Lipoproteins Chylomicron remnants HDL (Often transported as triglycerides of fatty acids bound to albumin or within lipoproteins)
328
Lipids from adipocytes to hepatocytes
Hormone sensitive lipase release free fatty acids Hepatic lipase enables the uptake into hepatocytes
329
Release of lipids from liver
Release controlled by hormones Released as VLDLs, energy substrates and detoxified substrates Storage capacity of far higher than demand
330
Lipids bypassing the liver
Chylomicrons can bypass the liver as transported by lymphatic system Protects liver from large fatty acid influx
331
3 locations of lipid oxidation in liver
Peroxysomal beta-oxidation Mitochondrial beta-oxidation ER Microsomal Ω -oxidation (CYP4a catalysed)
332
Lipid oxidation in the liver
Fatty acid oxidation is proportional plasma levels of free fatty acids released from adipocytes Peripheral fatty acid mobilisation when increased glucagon and decreased insukin
333
What causes fatty acid mobilisation
Increased glucagon Decreased insulin
334
What is fatty acid synthetase activated by
Insulin Substrate (citrate, isocitrate)
335
What is FA synthetase inactivated by
Catecholamines Glucagon
336
FAS
FA synthetase Negative feedback- high FAS in hepatocytes inhibit FAS Related to de novo lipogenesis in the liver
337
Mitochondrial beta-oxidation
Primarily involved in oxidation of fatty acids of various chain length Multistep process Progressive shortening into acetyl -CoA subunits - condensed into ketone bodies providing oxidisable energy to cells - enter tricarboxyl acid cycle- resulting in H20 and CO2
338
What is mitochondrial beta-oxidation regulated by
CPT (carnitine palmitosyl transferase), carnitine concentration and malonyl-CoA (which inhibits CPT)
339
What leads to hepatic steatosis
Genetic disorders inhibiting mitochondrial oxidation, certain drugs eg alcohol and toxins
340
Number of carbons - short chain fatty acid
<8
341
Number of carbons - medium chain fatty acid
8-12
342
Number of carbons - long chain fatty acid
12-20
343
Dicarbolic acids
Very toxic Inhibits mitochondrial fatty acid oxidation
344
Peroxisomal beta-oxidation
4 step process is repeatedly performed to shorten chain length Each step can be carried out by at least 2 enzymes
345
Disruption of Peroxisomal beta-oxidation
Leads to micro-vesicular steatosis
346
What are enzymes of Peroxisomal beta-oxidation induced by
PPARά
347
Main role of Peroxisomal beta-oxidation
detoxification of -very long chain fatty acids (>C 20) -2-methyl-branched FAs -Dicarbolic acids – very toxic – inhibiting mitochondrial fatty acid oxidation -Prostanoids -C-27 bile acid intermediaries
348
Microsomal Ω -oxidation
Normally a minor metabolic pathway but in fat overload increases CYP4A enzymes oxidise saturated and unsaturated fatty acids Ω-hydroxylation in the ER, followed by decarboxylation of the Ω-hydroxy fatty acid in the cytosol – in turn enter the β-oxidation pathway Dicarboxyl FA act as ligands to PPARά – induction of the oxidation systems
349
PPARά
Lipid sensor- gene transcription Its activity determines whether fatty acids are stored as triglycerides in hepatocytes or oxidised for energy
350
How do fatty acids regulate gene expression
Control activity of key transcription factors
351
Function of transcription factors
Integration of signals from diverse pathways Co-ordination of the metabolic machinery for fatty acid metabolism
352
Transcription factors controlled by fatty acids
Peroxisome proliferator-activated receptors (PPAR ά, β and γ) Retinoid X receptor (RXR) Sterol regulator element binding protein (SREBP)
353
Peroxisome proliferator activated receptor (PPAR)
All PPARs (ά, γ,β/ δ) are involved in lipid homeostasis PPAR ά and β/ δ facilitate energy combustion PPAR γ facilitates energy storage PPAR ά is a lipid sensor – gene transcription Reduced PPAR ά sensing/activity leads to steatosis, possible by induction of CYP2E1, proinflammatory cytokines and TFN ά
354
Role of PPAR ά and β/ δ
Facilitate energy combustion
355
PPAR γ
Facilitates energy storage
356
Reduced PPAR ά
sensing/activity leads to steatosis, possible by induction of CYP2E1, proinflammatory cytokines and TFN ά
357
Adiposities
Increased energy storage
358
Developing fatty liver
Increase plasma in fatty acids (mainly in TG) Excess dietary fat intake Excess dietary caloric intake overall But also increased flux of FAs Increased release of FAs from adipocytes Increased FA uptake in hepatocytes Decreased FA oxidation Decreased demand for lipids for fuel leading to increased storage Resulting in bland steatosis Insulin resistance augments the process
359
Non-alcoholic fatty liver
Overstorage of unmetabolised energy exceeding the energy combustion capability of the PPAR a mediated system
360
Hepatic steatosis
Fat content exceeding 5-10% of the weight of the liver
361
Incidence of NAFL - diabetic patients
50%
362
Incidence of NAFL - obese patients
75%
363
Incidence of NAFL - morbidly obese patients
98%
364
Steatohepatitis
Increased steatosis (bland) Apoptosis of fat-laden hepatocyte releases TG and toxic FAs FAs induce CYP2E1 & FA oxidation systems →generation of reactive oxygen species (ROS) resulting in oxidative stress Oxidative stress induces release of proinflammatory cytokines from Kupffer cells (hepatitis) and ROS (and ethanol) activates stellate cells (fibrogenesis) Lipidperoxidation products develop immunogenic properties causing inflammation Gut derived products (e.g. endotoxins) also activate Kupffer cells
365
causes of change from NAFLD—>NASH
Adipose tissue inflammation Gut microbiota Oxidative stress Hepatocyte apoptosis Hepatic inflammation
366
Stages of NAFLD
1 simple fatty liver (steatosis) - a largely harmless build-up of fat in the liver cells that may only be diagnosed during tests carried out for another reason. Benign and no liver damage. Reversible 2 non-alcoholic steatohepatitis (NASH) - a more serious form of NAFLD, where the liver has become inflamed- estimated to affect up to 5% of the UK population 3 fibrosis - where persistent inflammation causes scar tissue around the liver and nearby blood vessels, but the liver is still able to function normally 4 cirrhosis - the most severe stage, occurring after years of inflammation, where the liver shrinks and becomes scarred and lumpy; this damage is permanent and can lead to liver failure and liver cancer
367
Stage 1 of NAFLD
simple fatty liver (steatosis) - a largely harmless build-up of fat in the liver cells that may only be diagnosed during tests carried out for another reason. Benign and no liver damage Reversible
368
Stage 2 of NAFLD
non-alcoholic steatohepatitis (NASH) - a more serious form of NAFLD, where the liver has become inflamed- estimated to affect up to 5% of the UK population
369
Stage 3 of NAFLD
fibrosis - where persistent inflammation causes scar tissue around the liver and nearby blood vessels, but the liver is still able to function normally
370
Stage 4 of NAFLD
cirrhosis - the most severe stage, occurring after years of inflammation, where the liver shrinks and becomes scarred and lumpy; this damage is permanent and can lead to liver failure and liver cancer
371
Management of fatty liver disease
Diet and exercise ↓ Supply - Reduced intake of calories ↑ Demand – increased consumption The body will get energy from the “compartment” least in demand e.g. Exercise – fat burning Illness – muscle protein utilisation
372
Alcohol and liver fat
High caloric load – energy load Metabolised in the liver – increased load leads to: Impairment and inhibition of PPARά and SREBP PPARά ↓ - ↓ fat oxidation SREBP ↓ - ↑ FAS - lipogenesis Damage to cell organelles – mitochondria, ER – reduced fat oxidation Apoptotic hepatocytes release TG and very-long chain FA – augment liver injury Stellate cell activation –leading to increased fibrogenesis
373
Conditionally essential amino acid
Under certain circumstances they may be needed to be consumed in the diet eg dependent on consumption of other amino acids
374
Examples of conditionally essential amino acids
Arginine Cysteine Glycine Glutamine Proline Tyrosine
375
Universal acceptor of amine groups
Alpha-ketoglutarate
376
Transamination
Turning an amino acid into an intermediate in the TCA cycle Catalysed an amino transferase eg pyridoxal phosphate (PLP) dervived from vitamin B6 Taking an amine group from an amino acid to an alpha-ketoacid Turns it into an amino acid and becomes and alpha-ketoacid itself
377
What is pyridoxal phosphate derived from
Vitamin B6
378
Deamination
Glutamate is converted back to alpha-ketoglutamate by glutamate dehydrogenase Produces ammonia Remove via the urea cycle
379
Molecular weight of albumin
66 kDa
380
g/day of albumin produced by the liver
9-12 Can increase to 36
381
Transcapillary escape rate
Rate of movement of albumin between vessels
382
How does albumin leave circulation
Interstitium
383
How is albumin returned to circulation
Thoracic duct (lymphatics)
384
Functions of albumin
Binding and transport Maintenance of colloid osmotic pressure Free radicals Anticoagulant effects
385
Fed (anabolic) state
Amino acid surplus to requirement for protein synthesis can be metabolised to non-nitrogenous substances Eg glucose , glycogen or fatty acids Can be oxidised to generate ATP
386
Fasting (catabolic) state
Alanine transported to hepatocytes in large quantities Alanine aminotransferase transaminates the amino group from glutamate- producing pyruvate Pyruvate substrate in TCA cycle to form glucose Glutamate recycled back and urea is formed Glucose taken up by muscle cells and used in glycolysis Pyruvate produced and lactate released as a by-product Pyruvate then converted back to alanine
387
Glucose-alanine cycle - removal
Moves carbon atoms of pyruvate Moves excess ammonia from muscle to liver as alanine In liver, alanine yields pyruvate- starting block for gluconeogenesis Releases ammonia for conversion into urea] Energetic burden of gluconeogenesis imposed on liver rather than muscle (muscle ATP devoted to muscle contraction)
388
Pyruvate is the metabolic precursor for
Alanine
389
Oxaloacetate is the metabolic precursor for
Aspartate Asparagine
390
Alpha-ketoglutarate is the metabolic precursor for
Glutamate Glutamine Proline Arginine
391
3-phosphoglycerate is the metabolic precursor for
Serine Cysteine Glycine
392
Phosphoenolpyruvate and erythrose-4-P is the metabolic precursor for
Tyrosine
393
Which hormone drives all metabolic pathways in fed state
Insulin
394
Pathways of increased glucose in liver in fed state
1. Glycogenesis 2. Pentose phosphate pathway 3. Formation of GA3P and DHAP to then form 2 pyruvate 4. Fatty acid synthesis
395
Pentose phosphate pathway
Forms ribose-5-phosphate from glucose Generates NADPH
396
If high levels of Acetyl-CoA in the liver
Kreb’s cycle inhibited Citrate is broken down into oxaloacetate and acetyl-coa by citrate ligase Acety-CoA is converted to malonyl-CoA—-> fatty acids
397
Intermediate between acetyl-CoA and fatty acids
Malonyl-CoA
398
Where does the urea cycle take place
Partly in the cytosol and partly in the mitochondria
399
Control of the urea cycle
Via up/down regulation of the enzymes responsible Long-term changes in level of dietary protein can result in 20-fold up regulation - could be seen in both high protein diets and starvation (protein breakdown)
400
The urea cycle overview
1. Ammonia enters cycle by a Transamination reaction to form glutamate (recycle by deamination) 2. NH3 moves into the mitochondria and reacts with HCO3- (with ATP) to form carbamoyl phosphate catalysed by carbamoyl phosphate synthase 3. Carbmoyl phosphate reacts with ornithine to form citrulline catalysed by ornithine transcarbamylase 4. Moves out into cytoplasm through transporter 5. Reacts with aspartate and ATP to form arginine succinate catalysed by argininosuccinate synthase 6. This breaks down into arginine and releases demarcate catalysed by argininosuccinate lyase 7. Arginine reacts with water to produce ornithine releasing urea catalysed by arginase/ornithine aminotransferase 8. Ornithine then re-enters the mitochondria to continue the cycle
401
Major proteins synthesised in the liver
Albumin CRP Hormone binding globulins Apolipoproteins Other transport proteins eg caeruloplasmin, ferritin Factors in the complement cascade Inhibitors of clotting Fibrinolysis Inhibitors of fibrinolysis Complement
402
Which proteins does the liver not synthesise
Immunoglobulins
403
What charge does albumin have
Negative
404
Causes of hypoalbuminaemia
Inflammation Liver disease Renal disease Burns/trauma Sepsis Malnutrition
405
Consequences of hypoalbuminaemia
Oedema Effusions Carrier proteins
406
Albumin calculations
Exudates vs Transudates Adjusting for electrolytes – esp Ca2+ Adjusting for hormone levels – eg free testosterone Renal disease
407
Chronic liver disease and bleeding
Reduced synthesis of clotting factors -Hepatic dysfunction -Vitamin K deficiency/malabsorption Reduced synthesis of inhibitors Production of abnormal/dysfunctional proteins Enhanced fibrolytic activity -Reduced clearance of activators of fibrinolysis -Reduced production of inhibitors Reduced hepatic clearance of clotting factors Disseminated intravascular coagulation -Multifactorial – includes endotoxaemia Platelet abnormalities -Number -Function Development of varices
408
Which vitamin is required for the liver to produce clotting factors
Vitamin K
409
How is NH4+ produced via catabolism
Amino acid split into alpha-keto acid and NH4+
410
Hypoalbuminaemia
Low blood albumin
411
Urea cycles treatment
Avoidance of catabolism, glucose polymers when unwell Induction of anabolism – give dextrose 10% 2ml/kg/hr -> insulin! Low dietary protein, arginine, benzoate, phenylbutyrate Haemofiltration Liver transplantation, umbilical vein hepatocyte transfusion Gene therapy: NIH NGVL UPenn trial stopped after death (adenovirus E1 E4 del., fever, multi-organ failure)
412
What is the only anabolic hormone
Insulin
413
Energy requirements of 1 cycle of urea cycle
Consumes 3 ATP molecules 4 high energy nucleotide PO4-
414
How is the energy consumed by urea production generated
Production of the cycle intermediates
415
Products of urea cycle
Urea is only compound generated Other components are all recycled
416
How does ammonia enter urea cycle
Transamination reaction to form glutamate
417
How is glutamate recycled
Deaminatiom
418
What does NH3 react with to form carbamoyl phosphate in urea cycle
HCO3- with ATP
419
NH3 and HCO3- forms
carbamoyl phosphate
420
Which enzyme catalyses production of carbamoyl phosphate
carbamoyl phosphate synthase
421
What does carbamoyl phosphate react with to form citrulline
Ornithine
422
carbamoyl phosphate and ornithine forms
Citrulline
423
Which enzymes catalyses formation of citrulline
Ornithine transcarbamylase
424
At what stage does the urea cycle go from mitochondria to cytoplasm
Citrulline moves out of mitochondria via a transporter
425
What does citrulline react with to form arginine succinate
Aspartate and ATP
426
Fate of NH4+
Biosynthesis of amino acids, nucleotides and biological amines Excretion
427
Citrulline and aspartate forms
Arginine succinate
428
Which enzyme catalyses production of arginine succinate
Argininosuccinate synthase
429
What does arginine succinate break down into
Arginine and fumarate
430
Which enzyme catalyses the break down of arginine succinate
Argininosuccinate lyase
431
What does arginine react with to produce ornithine
Water
432
Arginine and water form
Ornithine and releases urea
433
Which enzyme catalyses production ornithine and urea
Arginase/ornithine aminotransferase
434
How are the urea cycle and TCA cycle linked
Through the aspartate-argininosuccinate shunt of the TCA cycle
435
Which molecule produced in the urea cycle enters the TCA cycle
Fumarate
436
Urea and TCA cycle
Fumarate produced by argininosuccinate lyase enters the TCA cycle Converted to oxaloacetate Oxaloacetate accepts an amino group from glutamate (transamination) Forms aspartate - leaves mitochondria Donates its amino group to the urea cycle in the argininosuccinate synthetase reaction Intermediates in the citric acid cycle are boxed
437
What is added to oxaloacetate to form aspartate
Amino group from glutamate (transamination)
438
Main problem with high ammonia
Neurotoxicity Ammonia crosses the blood-brain barrier readily. Once inside it is converted to glutamate via glutamate dehydrogenase and so depletes the brain of α ketoglutarate. As ketoglutarate falls, so does oxaloacetate and ultimately citric acid cycle activity stops, leading to irreparable cell damage and neural cell death
439
Early feature of hyperammonaemia
Respiratory alkalosis
440
Bile acid function
Removal of lipid soluble xenobiotics/drug metabolites/heavy metals Induce bile flow and secretion of biliary lipids Digestion of dietary fat Facilitates protein absorption Cholesterol homeostasis Anti microbial Induce bile flow and solubilise cholesterol Prevents calcium gallstones and oxalate renal stones
441
Bile acid function- digestion of dietary fats
By solubilising lipids and lipid digestion products as mixed micelles facilitating aqueous diffusion across intestinal mucosa
442
Bile acid function- facilitates protein absorption
Accelerating hydrolysis by pancreatic proteases
443
Bile acid function- cholesterol homeostasis
Facilitates dietary absorption/elimination as bile acids are water soluble end products of cholesterol catabolism
444
Bile acid function- induce bile flow and solubilise cholesterol
Enabling movement from hepatocyte to intestinal lumen
445
Bile acid function- anti microbial
Physicochemical and inducing anti-microbial genes
446
Bile acid composition
Water Inorganic electrolytes Organic solutes- bile acids, phospholipids, cholesterol, pigment
447
Faecal bile acids (secondary)
2/3 deoxycholic 1/2 lithocholic
448
Hepatic/gallbladder bile
2/3 bile acids (primary) -cholic- 1/3 -chenodeoxycholic 1/3 Deoxycholic 1/3 -lithocholic and ursodeoxycholic 1/4 phospholipids Small amounts of cholesterol, bilirubin, proteins
449
Bile production per day
500-600 ml
450
Primary Bile acid production
Synthesised from cholesterol in hepatocytes Converted into cholic acid and chenodeoxycholic acid Enzyme = CYP7A1 Conjugated with glycine/taurine before secretion into bile canaliculi
451
Coagulation effects on bile salts
Increases hydrophilicity Increases acidic strength of the side chain Decreases passive diffusion of bile across cell membranes (keeps it intraluminal)
452
Secondary bile acid production
Presence of intestinal bacteria converts primary to secondary Enzyme = 7 alpha-dehydroxylase
453
Which enzyme converts primary bile salts to secondary bile salts
7 alpha-dehydroxylase
454
Formation of bile salts is dependent on
Hepatic synthesis and canalicular secretion of bile acids (major organic anion in bile)
455
Which enzyme converts cholesterol into cholic acid and chenodeoxycholic acid
CYP7A1
456
Two main acids cholesterol is converted into to form bile acids
Cholic acid Chenodeoxycholic acid
457
Number of enterohepatic circulation cycles per meal
2-3
458
Regulation of bile acid secretion- fasted state
Bile acids travel down biliary tract to the gallbladder where it is concentrated 10-fold
459
Regulation of bile acid secretion- fed state
CCK released from duodenal mucosa
460
Effects of CCK on bile acid secretion
Relaxes sphincter of Oddi Contracts gallbladder Releasing concentrated solution of mixed micelles (bile acid, phospholipids, cholesterol)
461
Reabsorption of bile acids
Conjugated bile acids remain intraluminal Some reabsorbed passively in Jejunum-ileum Actively transported via the apical sodium bile acid transporter in the ileum Re-enters liver via portal circulation Bile acids take up by hepatocytes and re-conjugated secreted into biliary canaliculi
462
Negative feedback mechanism- bile acids
Too much bile acid Ligand for farnisoid X receptor in ileum Results in synthesis of FGF-19 (endocrine polypeptide molecule) Inhibition of CYP7A1 (cholesterol 7 alpha hydroxylase) - first step in converting cholesterol into bile acids
463
What are bile acids a ligand for
Farnisoid X receptor in ileum
464
Activation of farnisoid X receptor synthesises
FGF-19
465
What does FGF-19 inhibit
CYP7A1
466
What inhibits formation of cholesterol
Statins- inhibit HMG CoA reductase
467
What reduces absorption of cholesterol
Ezetimibe- stops protein mediated transport across enterocyte membrane
468
Excess amino acids —> fatty acids
Amino acids —> Acetyl-CoA—> citrate—> acetyl-CoA —> malonyl CoA—> fatty acids
469
3 fates of cholesterol in the liver
1. Bile acids - CYP7A1 2. Cholesterol esters for storage - ACAT 3. Combine with triglycerides to form VLDLs
470
What is produced in skeletal or adipose tissue from VLDL
IDL (intermediate density lipoprotein) Cells use triglycerides and cholesterol
471
IDL —> LDL
Loss of cholesterol
472
Main hormones for fasting state metabolism
Glucagon Cortisol Growth hormone Adrenaline Noradrenaline Thyroid hormone
473
Bile acids are amphipathic
Reduce surface tension Aid emulsification
474
Ileal resection or disease
unabsorbed bile acids enter colon where inhibit water absorption / induce secretion resulting in ‘bile salt diarrhoea’
475
Cholecystectomy
daily bile acid secretion is not altered much. Bile is ‘stored’ in proximal small intestine – likely big ‘shift’ to distal small intestine ‘overwhelms’ transport mechanism or feedback mechanism
476
Biliary obstruction
CBD stone, pancreatic carcinoma – intestinal malabsorption of fat soluble vitamins and fat resulting in steatorrhoea and develop jaundice
477
Disruption of enterohepatic circulation may be due to
bacterial overgrowth- deconjugation of bile acids cholecystectomy ileal resection may result in diarrhoea / steatorrhoea malabsorption of fat soluble vitamins
478
Small intestinal bacterial overgrowth
Alteration of number/composition of bacteria in small intestine Bloating, diarrhoea, abdominal pain Treat with antibiotics
479
Which cells store vitamin C
None
480
What clotting factors are vitamin K dependent
Factor II, VII, IX X
481
Which hormone acts on the gallbladder to cause pain when suffering from gallstones
Cholecystokinin CCK- causes contraction of gallbladder but flow of bile is obstructed
482
What is the relationship between bile acid synthesis in the liver and bile acid reabsorption in the small intestine
Inversely proportional More bile acid reabsorbed— > bile acids recycled and re-secreted via enterohepatic cycle so less bile acids produced
483
What stimulates bile secretion
Presence of partially digested fats and proteins in duodenum Cholecystokinin and secretin released CCK acts on gallbladder to secrete bile Secretin stimulates biliary duct cells to secrete bicarbonate and water - expanding volume of bile
484
How does glucose-6-dehydrogenase deficiency cause jaundice
Erythrocytes more susceptible to to oxidative stress Increased haemolysis
485
Where is iron stored in the body
Liver Spleen Bone marrow
486
Gilbert’s syndrome
Non-functional glucuronyl transferase
487
Why does jaundice cause itchy skin
Build up of bile salts
488
Serum concentration of bilirubin to be able to see yellow skin cause of jaundice
50 mmol/L
489
Serum concentration of bilirubin- jaundice
> 21 mmol/L
490
Bilirubin is the by-product of Haemoglobin breakdown. Microsomal enzyme uridine diphosphoglucoronosyl transferase (glucuronyl transferase) catalyses the formation of what?
Conjugated bilirubin
491
A 53 year old patient is admitted with jaundice. Which of the following causes an increased serum unconjugated (free) bilirubin and increased faecal urobilinogen?
Pre-hepatic
492
Which coagulation factors does the liver produce
1972: - 10 -9 -7 -2
493
Which cells store iron in the form of ferritin
Kupffer cells
494
Haemoglobin is the chemical responsible for carrying oxygen around the body, the products of its breakdown give urine and faeces their distinct colours. In one stage of the breakdown of haemoglobin, unconjugated bilirubin is converted to conjugated bilirubin. This process occurs in the liver. What enzyme is responsible for converting unconjugated bilirubin to conjugated bilirubin?
Glucuronyl transferase
495
Carbamoyl phosphate synthetase deficiency I is an autosomal recessive disorder which causes toxic ammonia to accumulate in the body. Babies born with this disorder have a deficiency of the enzyme carbamoyl phosphate synthetase. In severe cases, this leads to respiratory distress, seizures and coma. What stage of the urea cycle is the enzyme carbamoyl phosphate synthetase important for?
Conversion of ornithine to citrulline
496
Albumin, which is produced in the liver, is a vital plasma protein that has many functions in the body. Which of the following is NOT a function of albumin?
Bind to and transport iron